Skip to content

EBIT at other companies

Astrana Health logo
Astrana HealthASTH
$28.53M+38.6%
Agilon Health logo
Agilon HealthAGL
$4M+118%
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
$69.33M+33.8%
Humana logo
HumanaHUM
CVS Health logo
CVS HealthCVS
UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+170%
Enterprise value$1.31B+143%
P/S1.4×+0.8×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Calculated from InnovAge Holdings, Inc.’s reported figures.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s EBIT?
InnovAge Holdings, Inc. (INNV) reported EBIT of -$29.08M in Q1 2026.
How has InnovAge Holdings, Inc.'s EBIT changed year-over-year?
InnovAge Holdings, Inc.'s EBIT decreased by 186.3% year-over-year, from -$10.16M to -$29.08M.
What is the long-term trend for InnovAge Holdings, Inc.'s EBIT?
Over 3 years (2022 to 2025), InnovAge Holdings, Inc.'s EBIT has grown at a 89.0% compound annual growth rate (CAGR), from -$4.41M to -$29.76M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.